Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • TransCelerate pharmaceuticals news

    TransCelerate BioPharma Inc., Philadelphia, Pa. Business: Pharmaceuticals Not-for-profit biopharma consortium TransCelerate added Merck & Co. Inc. (NYSE:MRK, Whitehouse Station, N.J.) and Novo Nordisk A/S (CSE:NVO; NYSE…

    Published on 2/2/2015
  • American Society of Clinical Oncology, SAP SE other news

    American Society of Clinical Oncology, Alexandria, Va. SAP SE (NYSE:SAP; Xetra:SAP), Walldorf, Germany Business: Other ASCO said software company SAP will provide computing infrastructure for the organizations …

    Published on 1/26/2015
  • J&J, Yale University other news

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Yale University, New Haven, Conn. Business: Other Johnson & Johnson agreed to make de-identified patient-level data from clinical trials of its medical devices and …

    Published on 1/26/2015
  • Teva, Momenta, Novartis autoimmune news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), Cambridge, Mass. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Autoimmune The U.S. …

    Published on 1/26/2015
  • Aveo Pharmaceuticals cancer news

    Aveo Pharmaceuticals Inc. (NASDAQ:AVEO), Cambridge, Mass. Business: Cancer Aveo eliminated its internal research function and reduced headcount by 40 (67%) to 20 to focus resources on advancing its clinical pipeline. …

    Published on 1/19/2015
  • Bavarian Nordic, J&J infectious news

    Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Infectious The EUs Innovative Medicines Initiative (IMI) awarded over 100 million ($118.2 million) to …

    Published on 1/19/2015
  • Cel-Sci, inVentiv Health cancer news

    Cel-Sci Corp. (NYSE-M:CVM), Vienna, Va. inVentiv Health Inc., Burlington, Mass. Business: Cancer Cel-Sci said an arbitration trial regarding its claim against inVentivs CRO, inVentiv Health Clinical, is scheduled for …

    Published on 1/19/2015
  • Cytori, U.S. Department of Health and Human Services gene/cell therapy, other news

    Cytori Therapeutics Inc. (NASDAQ:CYTX; Xetra:XMPA), San Diego, Calif. U.S. Department of Health and Human Services, Washington, D.C. Business: Gene/Cell therapy, Other HHSs Biomedical Advanced Research and Development …

    Published on 1/19/2015
  • Daiichi Sankyo pharmaceuticals news

    Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan Business: Pharmaceuticals Daiichi will pay about $39 million, plus fees and costs, under a civil settlement with the U.S. government and participating states to …

    Published on 1/19/2015
  • Gilead infectious news

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Infectious The Indian Patent Office rejected Gileads patent application covering HCV product Sovaldi sofosbuvir. The patent office issued a decision …

    Published on 1/19/2015
  • NewLink, Merck, U.S. Department of Health and Human Services infectious news

    NewLink Genetics Corp. (NASDAQ:NLNK), Ames, Iowa Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced …

    Published on 1/19/2015
  • Cempra, U.S. Department of Health and Human Services infectious news

    Cempra Inc. (NASDAQ:CEMP), Chapel Hill, N.C. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) exercised its first …

    Published on 1/12/2015
  • Cubist, Hospira infectious news

    Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Business: Infectious The U.S. District Court for the District of Delaware ruled that Cubists antibiotic Cubicin …

    Published on 1/12/2015
  • Kymab, Public Health England, University of Westminster, Wellcome Trust, Wellcome Trust Sanger Institute infectious news

    Kymab Ltd., Cambridge, U.K. Public Health England, Salisbury, U.K. University of Westminster, London, U.K. Wellcome Trust, London, U.K. Wellcome Trust Sanger Institute, Cambridge, U.K Business: Infectious Wellcome Trust…

    Published on 1/12/2015
  • Ranbaxy generics, gastrointestinal, infectious news

    Ranbaxy Laboratories Ltd. (NSE:RANBAXY; BSE:500359), Gurgaon, India Business: Generics, Gastrointestinal, Infectious Ranbaxy filed a suit in the U.S. District Court for the District of Columbia alleging that FDA …

    Published on 1/12/2015
  • Dendreon cancer news

    Dendreon Corp. (Pink:DNDNQ), Seattle, Wash. Business: Cancer The U.S. Bankruptcy Court for the District of Delaware approved bidding and auction procedures for Dendreon to sell off substantially all of its assets. The …

    Published on 1/5/2015
  • Tengion genitourinary, gene/cell therapy, transplant news

    Tengion Inc. (OTCQB:TNGN), Winston-Salem, N.C. Business: Genitourinary, Gene/Cell therapy, Transplant Regenerative medicine company Tengion filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District …

    Published on 1/5/2015
  • Ambry Genetics, Myriad Genetics diagnostic news

    Ambry Genetics Corp., Aliso Viejo, Calif. Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Business: Diagnostic The U.S. Court of Appeals for the Federal Circuit (CAFC) ruled that a district court correctly …

    Published on 12/22/2014
  • American Lung Association, FNIH cancer news

    American Lung Association (ALA), Chicago, Ill. Foundation for the National Institutes of Health (FNIH), Bethesda, Md. Business: Cancer ALA partnered with FNIH to promote the Phase II/III Lung-MAP trial, a master …

    Published on 12/22/2014
  • Bayer, Natco cancer, generics news

    Bayer AG (Xetra:BAYN), Leverkusen, Germany Natco Pharma Ltd. (BSE:NATCO; NSE:NATCOPHARM), Hyderabad, India Business: Cancer, Generics Indias Supreme Court dismissed a special leave petition by Bayer to appeal a 2012 …

    Published on 12/22/2014
  • Stanford University inflammation news

    Stanford University, Stanford, Calif. Business: Inflammation Silicon Valley entrepreneur Sean Parker pledged $24 million over the next two years to establish a research center at the Stanford University School of …

    Published on 12/22/2014
  • Veloxis Pharmaceuticals transplant news

    Veloxis Pharmaceuticals A/S (CSE:VELO), Horsholm, Denmark Business: Transplant Veloxis filed suit in the U.S. District Court for the District of Columbia seeking an order requiring FDA to grant final approval to …

    Published on 12/22/2014
  • Yumanity Therapeutics neurology news

    Yumanity Therapeutics LLC, Cambridge, Mass. Business: Neurology Former Onyx Pharmaceuticals Inc. CEO Tony Coles and Massachusetts Institute of Technology Professor Susan Lindquist launched Yumanity to discover …

    Published on 12/22/2014
  • Alnylam pharmaceuticals news

    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Pharmaceuticals Alnylam outlined plans to focus its RNAi pipeline on genetic medicine, cardio-metabolic diseases and hepatic infectious diseases. …

    Published on 12/15/2014
  • Amgen, Novartis, Pfizer autoimmune news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Autoimmune U.S. Court of Appeals for the Federal Circuit affirmed a …

    Published on 12/15/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993